Hypertension, use of antihypertensive medications and breast cancer survival among Black women
Blood pressure medications show unexpected promise for improving survival in Black women with a common type of breast cancer.
This prospective study of 2,474 Black women with breast cancer finds that antihypertensive treatment is strongly associated with lower breast cancer-specific mortality among ER+ cases (HR 0.53), a subgroup-specific signal that warrants further investigation for drug-repurposing or comorbidity management implications. The population focus on Black women — who experience disproportionately high breast cancer mortality and high rates of hypertension — represents an important equity signal.
What the study was
- Study design
- Prospective cohort (Black Women's Health Study); n=2474 Black women with invasive breast cancer; Cox proportional hazards models adjusted for clinical, lifestyle, and cancer treatment factors
- Population
- Black women in the United States with confirmed invasive breast cancer (Black Women's Health Study participants)
- Sample size
- 2474
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Breast Cancer Research
Why it surfaced
Prospective cohort in underserved population (Black women) with breast cancer identifies strong HR 0.53 association of antihypertensive treatment with ER+ breast cancer-specific survival. Potential drug-repurposing signal and equity implication. Design quality capped at 1 due to observational nature and subgroup analysis (HR 0.81 non-significant in full cohort); evidence maturity set to Exploratory. Flagged unsolicited_find=true as sentinel discovery.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.